Zikhona Njengele-Tetyana

Dr. Zikhona Njengele-Tetyana

Mintek, Johannesburg, Gauteng, South Africa
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2013 in IUBMB Life
Verified
Journal Article
Open access
PDF file
RKRose Kadye
Rose Kadye
AKAdam H. Kramer
Adam H. Kramer
JJJulia Joos-Vandewalle
Julia Joos-Vandewalle
MPMichelle Parsons
Michelle Parsons
ZNZikhona Njengele-Tetyana
Zikhona Njengele-Tetyana
EPEarl Prinsloo
Earl Prinsloo
Mitochondria are key to eukaryotic cell survival and their activity is linked to generation of reactive oxygen species (ROS) which in turn acts as both an intracellular signal and an effective executioner of cells with regards to cellular senescence. The mitochondrial molecular chaperone tumor necrosis factor receptor associated protein 1 (TRAP1) is often termed the cytoprotective chaperone for its role in cancer cell survival and protection from apoptosis. Here, we hypothesize that TRAP1 serves to modulate mitochondrial activity in stem cell maintenance, survival and differentiation. © 2013 IUBMB Life, 66(1):42–45, 2014

2 November 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
TDThulaganyo Domfe
Thulaganyo Domfe
ZNZikhona Njengele-Tetyana
Zikhona Njengele-Tetyana
NMNikiwe Mhlanga
Nikiwe Mhlanga
PTPhumlani Tetyana
Phumlani Tetyana
ASAmanda Skepu
Amanda Skepu
LSLucky Mashudu Sikhwivhilu
Lucky Mashudu Sikhwivhilu
Rift Valley fever (RVF) is a mosquito-borne zoonotic disease that is caused by the Rift Valley fever virus (RVFV); Bunyaviridae: Phlebovirus. RVF disease can affect several different species, including ruminants, camels and humans and thus present a dual threat to public health and livestock food production in endemic regions. In livestock, the RVFV infection is characterised by an acute hepatitis, abortion and high mortality rates in new-born animals. The current RVF diagnostic techniques have shown good sensitivity. However, they require extensive sample processing and complex instrumentation. Owing to speed, low cost, ease of use, and most importantly, the ability to diagnose diseases at sites where they are managed, lateral flow immunoassays (LFIA) are the most widely used point-of-care (POC) tools for disease diagnosis. In this study, a lateral flow assay (LFA) device that is able to detect antibodies against RVFV, with a minimum detectable concentration of 0.125 mg/mL, was successfully developed. The LFA also successfully detected RVFV antibodies in reference RVFV sera. Protein A (ProA), which has the ability to bind immunoglobulins from different species, was used in the detection probe, giving the developed RVFV LFA potential for multi-species diagnosis.

1 December 2016 in Protein Expression and Purification
Verified
Journal Article
Closed access
ZNZikhona Njengele-Tetyana
Zikhona Njengele-Tetyana
RKRonel Kleynhans
Ronel Kleynhans
YSYasien Sayed
Yasien Sayed
SMSalerwe Mosebi
Salerwe Mosebi

1 December 2021 in Protein Expression and Purification
Verified
Journal Article
Closed access
AMAmukelani Marivate
Amukelani Marivate
ZNZikhona Njengele-Tetyana
Zikhona Njengele-Tetyana
MFMuhammad Qasim Fish
Muhammad Qasim Fish
SMSalerwe Mosebi
Salerwe Mosebi